Anteris Technologies Global Corp (AVR) Stock Price, Quote & News

Company Profile

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into dura...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 61 7 3152 3200

Website: anteristech.com

Address:

Toowong Tower, Level 3, Suite 302 9 Sherwood Road, Toowong, Australia

BioTuesdays Jun. 8 at 4:55 PM

$AVR has received full regulatory clearance from the French National Agency for Medicines and Health Products Safety (ANSM) enabling patient recruitment to begin in France for the DurAVR Transcatheter Heart Valve (THV) global PARADIGM pivotal trial in patients with severe calcific aortic stenosis. https://biotuesdays.com/2026/06/08/ansm-grants-clearance-for-anteris-trial-of-transcatheter-heart-valve/

0 · Reply

double20sixteentimes Jun. 8 at 4:54 PM

$AVR no volume. zero.

0 · Reply

EmDavis34 Jun. 8 at 12:22 PM

$AVR we aren't done here!

0 · Reply

Dockyy Jun. 5 at 10:53 AM

$AVR Never forget Medtronic owns 15% of this. This unique valve will bring their arsenal equal or better to Edwards Sapien. I follow this because I need a valve, and want this one. Done my DD. Am invested

1 · Reply

EmDavis34 Jun. 5 at 3:29 AM

$MX another stock I'm smacking around is $AVR I'm heavy on $10 June 18th calls. This will touch $11 tomorrow on no news. Depending on premarket, calls will probably open around .60, gonna grab 20 or 30.

0 · Reply

Spicy_Trade Jun. 5 at 2:24 AM

Anteris Technologies Global Cor ( $AVR ) SpicyTrade - Daily Stock Analysis https://youtu.be/0U8m0ds4VBs?si=VKXPeEnEt59IIUKi

0 · Reply

EmDavis34 Jun. 4 at 11:05 PM

$AVR over 10 👀👀

0 · Reply

EmDavis34 Jun. 4 at 8:54 PM

$AVR this will be over $10.50 tomorrow, same with $MX over $10

0 · Reply

hankbb02 Jun. 4 at 5:35 PM

$AVR this isnt a stock you trade, its a deep small cap value

3 · Reply

QuantInsider Jun. 4 at 4:31 PM

$AVR popping off today, up around 6% and 9% over the last five days Traders are hitting those short-dated $10 calls hard Looks like the options market is betting on more upside Watch out, volatility is already high so this is a momentum play with some risk Saw a big sweep of 1,957 Jun 18 $10 calls, about 4.5 times the prior open interest Price busted through $10 so keep an eye on that level It's a key spot for support or failure before diving into any new bullish moves

0 · Reply

Anteris Technologies (AVR) Secures Regulatory Approval for Heart Valve Trial

2026-06-08T10:12:00.000Z - 3 days ago

Anteris Technologies cleared by ANSM for DurAVR THV trial

Mon, 08 Jun 2026 06:00:00 -0400 - 3 days ago

Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance

2026-05-15T08:55:46.000Z - 27 days ago

Anteris Technologies price target raised to $18 from $17 at Barclays

Wed, 13 May 2026 08:39:00 -0400 - 4 weeks ago

Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors

2026-05-13T11:32:11.000Z - 4 weeks ago

How Should Investors Value Anteris Technologies Global Corp (AVR) After Q1 2026? EPS Not ...

Tue, 12 May 2026 19:00:00 -0400 - 4 weeks ago

Anteris Announces Results for the First Quarter of 2026

May 12, 2026, 6:00 PM EDT - 4 weeks ago

Anteris Technologies Global Earnings release: Q1 2026

May 12, 2026, 6:00 PM EDT - 4 weeks ago

Anteris Technologies Global Quarterly report: Q1 2026

2026-05-09T03:30:13.000Z - 4 weeks ago

Sio Capital Management, LLC's Strategic Acquisition in Anteris Technologies Global Corp

2026-05-05T10:28:40.000Z - 5 weeks ago

Anteris Technologies: First U.S. patients treated in global PARADIGM trial

Tue, 05 May 2026 06:00:00 -0400 - 5 weeks ago

Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial

2026-04-28T11:51:52.000Z - 6 weeks ago

Anteris Technologies (AVR) Achieves Medicare Reimbursement for PARADIGM Trial

2026-04-28T10:33:20.000Z - 6 weeks ago

Anteris Technologies secures CMS reimbursement for trial site activation

Tue, 28 Apr 2026 06:00:00 -0400 - 6 weeks ago

Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial

2026-03-12T16:03:29.000Z - 3 months ago

Anteris Technologies (AVR) Receives Overweight Rating from Cantor Fitzgerald | AVR Stock News

2026-03-12T11:35:42.000Z - 3 months ago

Anteris Technologies assumed with an Overweight at Cantor Fitzgerald

2026-03-11T11:01:12.000Z - 3 months ago

Anteris Technologies initiated with an Overweight at Wells Fargo

2026-03-11T00:00:26.000Z - 3 months ago

Anteris Technologies Global Corp at Barclays Global Healthcare Conference Transcript

Mar 10, 2026, 1:30 PM EDT - 3 months ago

Anteris Technologies Global Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 2, 2026, 3:10 PM EST - 3 months ago

Anteris Technologies Global Transcript: TD Cowen 46th Annual Health Care Conference

Thu, 26 Feb 2026 18:00:00 -0500 - 3 months ago

Anteris Reports 2025 Financial Results and Provides Corporate Update

Feb 25, 2026, 6:00 PM EST - 3 months ago

Anteris Technologies Global Annual report: H2 2025

Feb 25, 2026, 6:00 PM EST - 3 months ago

Anteris Technologies Global Annual report: H2 2025

2026-02-23T14:26:31.000Z - 3 months ago

Anteris Technologies price target lowered to $17 from $22 at Barclays

2026-01-23T14:01:04.000Z - 4 months ago

Anteris Technologies price target lowered to $15 from $20 at Lake Street

MDT

Jan 22, 2026, 4:02 PM EST - 5 months ago

Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises

Jan 22, 2026, 4:01 PM EST - 5 months ago

Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock

2026-01-22T13:36:05.000Z - 5 months ago

Ten new option listings and two option delistings on January 22nd

AARD BANX CLYM GRCE INR MENS NGEN

2026-01-21T10:29:11.000Z - 5 months ago

Anteris Technologies Surges On Pricing Of $200Mln Public Offering

2026-01-21T06:38:18.000Z - 5 months ago

What Sparked Anteris Technologies (AVR) Stock Surge Over 52% After-Hours?

2026-01-21T06:13:09.000Z - 5 months ago

Anteris Prices $200 Mln Public Offering; Announces Medtronic Private Placement Up To $90 Mln

Jan 20, 2026, 10:53 PM EST - 5 months ago

Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering

2026-01-20T21:11:59.000Z - 5 months ago

Anteris Technologies announces $200M common stock offering

2026-01-02T22:25:14.000Z - 5 months ago

Anteris Technologies files $500M mixed securities shelf

Jan 2, 2026, 7:00 AM EST - 5 months ago

Anteris Technologies Global Registration statement: Registration filing

Dec 3, 2025, 6:00 PM EST - 6 months ago

Anteris Technologies Global Transcript: AGM 2025

Dec 3, 2025, 6:00 PM EST - 6 months ago

Anteris Technologies Global Slides: FY 2025

2025-11-26T21:40:22.000Z - 7 months ago

Anteris Technologies files to sell 9.1M shares of common stock for holders

Nov 26, 2025, 7:00 AM EST - 7 months ago

Anteris Technologies Global Registration statement: Registration filing

2025-11-17T11:34:16.000Z - 7 months ago

Anteris Technologies (AVR) Reports Promising Results for DurAVR THV in Aortic Stenosis

2025-11-17T11:10:50.000Z - 7 months ago

Anteris Technologies Presents Data from 100 DurAVR(R) THV Patients at PCR London

Nov 17, 2025, 6:00 AM EST - 7 months ago

Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves

Nov 12, 2025, 6:00 PM EST - 7 months ago

Anteris Technologies Global Earnings release: Q3 2025

Nov 12, 2025, 6:00 PM EST - 7 months ago

Anteris Technologies Global Quarterly report: Q3 2025

Nov 12, 2025, 5:52 PM EST - 7 months ago

Anteris Announces Results for the Third Quarter of 2025

Nov 10, 2025, 7:00 AM EST - 7 months ago

Anteris Technologies Global Proxy statement: Proxy filing

Oct 30, 2025, 8:00 AM EDT - 8 months ago

Anteris Technologies Global Proxy statement: Proxy filing

2025-10-28T22:20:19.000Z - 8 months ago

Anteris Technologies reports clinical outcomes for DurAVR THV in patients

2025-10-27T21:50:19.000Z - 8 months ago

Anteris Technologies treats first patient in DurAVR heart valve pivotal trial

Oct 27, 2025, 5:43 PM EDT - 8 months ago

Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)

2025-10-27T12:50:49.000Z - 8 months ago

Anteris Technologies to present on one-year outcomes for DurAVR THV

Oct 27, 2025, 8:43 AM EDT - 8 months ago

Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025

Sep 19, 2025, 8:00 AM EDT - 9 months ago

Anteris Technologies Global Proxy statement: Proxy filing

Sep 19, 2025, 2:30 AM EDT - 9 months ago

Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders

Sep 11, 2025, 8:50 AM EDT - 9 months ago

Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders

Sep 11, 2025, 8:00 AM EDT - 9 months ago

Anteris Technologies Global Proxy statement: Proxy filing

Sep 4, 2025, 8:00 AM EDT - 10 months ago

Anteris Technologies Global Proxy statement: Proxy filing

Aug 18, 2025, 8:00 AM EDT - 10 months ago

Anteris Technologies Global Proxy statement: Proxy filing

Aug 11, 2025, 6:00 PM EDT - 10 months ago

Anteris Technologies Global Earnings release: Q2 2025

Aug 11, 2025, 6:00 PM EDT - 10 months ago

Anteris Technologies Global Quarterly report: Q2 2025

Aug 11, 2025, 4:52 PM EDT - 10 months ago

Anteris Announces Results for the Second Quarter of 2025

Aug 8, 2025, 8:00 AM EDT - 10 months ago

Anteris Technologies Global Proxy statement: Proxy filing

Jun 9, 2025, 10:52 PM EDT - 1 year ago

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

May 14, 2025, 3:30 AM EDT - 1 year ago

Anteris Technologies Global Earnings release: Q1 2025

May 14, 2025, 3:30 AM EDT - 1 year ago

Anteris Technologies Global Quarterly report: Q1 2025

Mar 31, 2025, 7:15 AM EDT - 1 year ago

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV

Mar 21, 2025, 7:30 AM EDT - 1 year ago

Anteris Reports One-Year Patient Outcomes for DurAVR® THV

Mar 12, 2025, 8:33 PM EDT - 1 year ago

Anteris Reports 2024 Financial Results and Provides Corporate Update

Mar 11, 2025, 7:00 PM EDT - 1 year ago

Anteris Technologies Global Annual report: H2 2024

Mar 11, 2025, 7:00 PM EDT - 1 year ago

Anteris Technologies Global Annual report: H2 2024

Mar 11, 2025, 9:00 AM EDT - 1 year ago

Anteris Technologies Global Transcript: Barclays 27th Annual Global Healthcare Conference

Mar 5, 2025, 9:10 AM EST - 1 year ago

Anteris Technologies Global Transcript: TD Cowen 45th Annual Healthcare Conference

Jan 12, 2025, 7:00 AM EST - 1 year ago

Anteris Technologies Global Slides: Investor Presentation

Dec 16, 2024, 7:49 PM EST - 1 year ago

Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering

Dec 12, 2024, 10:34 PM EST - 1 year ago

Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering

Dec 9, 2024, 7:43 AM EST - 1 year ago

Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering

BioTuesdays Jun. 8 at 4:55 PM

0 · Reply

double20sixteentimes Jun. 8 at 4:54 PM

$AVR no volume. zero.

0 · Reply

EmDavis34 Jun. 8 at 12:22 PM

$AVR we aren't done here!

0 · Reply

Dockyy Jun. 5 at 10:53 AM

1 · Reply

EmDavis34 Jun. 5 at 3:29 AM

0 · Reply

Spicy_Trade Jun. 5 at 2:24 AM

Anteris Technologies Global Cor ( $AVR ) SpicyTrade - Daily Stock Analysis https://youtu.be/0U8m0ds4VBs?si=VKXPeEnEt59IIUKi

0 · Reply

EmDavis34 Jun. 4 at 11:05 PM

$AVR over 10 👀👀

0 · Reply

EmDavis34 Jun. 4 at 8:54 PM

$AVR this will be over $10.50 tomorrow, same with $MX over $10

0 · Reply

hankbb02 Jun. 4 at 5:35 PM

$AVR this isnt a stock you trade, its a deep small cap value

3 · Reply

QuantInsider Jun. 4 at 4:31 PM

0 · Reply

Olivia_Strickland Jun. 4 at 3:12 PM

$AVR poppin 8.2% to 9.68 but only 0.35x avg vol, so the crowd isn't really here for it. these thin breakouts can reverse on you quick once the few buyers tap out. chart's doing the talking, no headline on my feed. where you think this fades or follows through? on my swing list now: https://tapeboard.com/scanner?utm_source=stocktwits&utm_medium=post&utm_campaign=olivia&utm_content=avr-bk-up-watch&utm_term=scanner&s=AVR

0 · Reply

ApexEquityVault Jun. 4 at 2:40 PM

$AVR gamma squeeze don’t miss it

0 · Reply

ApexEquityVault Jun. 4 at 2:39 PM

$AVR 10 Call 6/18 here 🚨

0 · Reply

ApexEquityVault Jun. 4 at 2:39 PM

High Confidence 🚨 $AVR 10 Call 6/18 at 0.60

0 · Reply

ApexEquityVault Jun. 4 at 2:39 PM

$AVR 10 Call 6/18 at 0.60

0 · Reply

VeltrixCapitalOfficial Jun. 4 at 2:38 PM

$AVR 10 CALL 6/18 @ .60 🐍🚨🚨

0 · Reply

Blockwave1 Jun. 4 at 2:37 PM

High Confidence 🚨 $AVR 10 Call 6/18 at 0.60

0 · Reply

Blockwave1 Jun. 4 at 2:37 PM

$AVR 10 Call 6/18 at 0.60 🚨

0 · Reply

STOCKGOD47 Jun. 2 at 8:07 PM

$AVR same story as $STRZ deep value play watch for continuation and probably a multi bagger

0 · Reply

Market Cap	924.75M
Revenue (ttm)	1.91M
Net Income (ttm)	-94.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-4,928.80%
Debt to Equity Ratio	0.00

Volume	978,100
Avg Vol	998,564
Day's Range	N/A - N/A
Shares Out	97.34M
Stochastic %K	51%
Beta	1.78
Analysts	Strong Sell
Price Target	$15.80